Comparison
1p35 2 Microdeletion Syndrome vs 14q12 Microdeletion Syndrome C4305240
Clinical comparison between 1p35 2 Microdeletion Syndrome and 14q12 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
1p35 2 Microdeletion Syndrome
0-null
14q12 Microdeletion Syndrome C4305240
0-1
Onset patterns differ
Severity
1p35 2 Microdeletion Syndrome
severe
14q12 Microdeletion Syndrome C4305240
moderate
Different severity levels
Chronic
1p35 2 Microdeletion Syndrome
Chronic
14q12 Microdeletion Syndrome C4305240
Chronic
Differing course
Communicable
1p35 2 Microdeletion Syndrome
No
14q12 Microdeletion Syndrome C4305240
No
Different transmission
Body System
1p35 2 Microdeletion Syndrome
congenital
14q12 Microdeletion Syndrome C4305240
congenital
Same/different system
Category
1p35 2 Microdeletion Syndrome
rare-disease
14q12 Microdeletion Syndrome C4305240
genetic
Different category
Bottom line
1p35-2-microdeletion-syndrome-C5679992 and 14q12-microdeletion-syndrome-C4305240 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1p35 2 Microdeletion Syndrome | 14q12 Microdeletion Syndrome C4305240 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Specific developmental features are not established in the supplied data. | Developmental delay and other health concerns may occur. | Moderate |
| Reported severity | Source axis labels severity as severe, but clinical proof is absent. | Source data label severity as moderate. | Low |
| Age at recognition | Onset is recorded as 0-null and is not clearly established. | Onset is recorded as infancy, age 0-1. | Moderate |
When to favor each condition
Choose 1p35 2 Microdeletion Syndrome when
A validated genetic result shows deletion involving 1p35.2
The chromosomal locus, not symptoms alone, identifies this concept.
High
A genetics report explicitly names 1p35.2 microdeletion syndrome
The named laboratory interpretation should guide concept selection.
High
Counseling follows a confirmed 1p35.2 finding
Discussion should remain tied to that result and its uncertainty.
Moderate
Choose 14q12 Microdeletion Syndrome C4305240 when
A validated result shows a microdeletion at 14q12
The 14q12 locus distinguishes this concept from 1p35.2.
High
An infant has developmental delay plus confirmed 14q12 deletion
The supplied description supports possible developmental delay, but the deletion is required.
Moderate
Documentation concerns a congenital chromosomal anomaly coded Q89.9
Q89.9 is listed for the right concept, but coding alone is not diagnostic.
Low
How key tests differ
| Test | 1p35 2 Microdeletion Syndrome | 14q12 Microdeletion Syndrome C4305240 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss involving 1p35.2 when present. | May show copy-number loss involving 14q12 when present. | An abnormal result suggests a locus; clinical correlation is still required. |
| Standard karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype does not exclude either microdeletion. |
| Parental genetic studies | Inheritance pattern is not established here. | Inheritance pattern is not established here. | Do not infer de novo or inherited status without parental results. |
Prognosis comparison
1p35 2 Microdeletion Syndrome
- Outcome
- Outcome is not established from the supplied data.
- Factors
- Reported severe label, chronic course, and confirmed locus may be relevant, but effects are unknown.
14q12 Microdeletion Syndrome C4305240
- Outcome
- Outcome is not quantified; supportive care is described.
- Factors
- Moderate severity label, infancy onset, developmental concerns, and chronic course are recorded.
Time frame: No reliable time frame or mortality estimate is established.
Locus, deletion extent, associated findings, and individual development require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Specific complications are not established. Developmental delay is described as possible. No definitive complication profile should be inferred from these sparse data. |
| Associated congenital anomalies | Not specified in the source. Other health concerns may occur, without a specified list. Absence from the source does not prove absence clinically. |
| Treatment-related burden | Management details are not supplied. Supportive, individualized care is described. No medication doses or treatment protocols are established here. |
Patient education highlights
- HighDiagnosis versus test result
A chromosomal finding needs clinician and genetics interpretation before it is treated as a diagnosis.
- HighLimited evidence
Available comparison data are sparse and do not predict exact symptoms, complications, or outcomes.
- MediumSupportive care
Care is individualized. Ask the care team which developmental and medical evaluations are appropriate.